GlassScriptPhysician profile
Charles D Bellamy
NPI 1043218803
$10,038.20
in general payments reported to CMS, 2019-2025
14 companies · $2,562 in 2025
The $2,562 reported for 2025 was more than what 86% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $747 · 2020: $1,096 · 2021: $779 · 2022: $782 · 2023: $1,487 · 2024: $2,585 · 2025: $2,562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,917 · Travel and Lodging: $2,718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,916.75 |
| Travel and Lodging | $2,717.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,574.60 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, Spectra Wavewriter |
| Pacira Pharmaceuticals Incorporated | $2,479.27 | 2019-2025 | Iovera, Exparel |
| Medtronic, INC. | $1,984.11 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Relievant Medsystems, INC. | $687.30 | 2023 | Intracept |
| Spr Therapeutics, INC | $521.93 | 2019-2022 | |
| Nevro Corp. | $238.94 | 2019-2021 | |
| Abbott Laboratories | $183.92 | 2022-2025 | Proclaim, Eterna |
| Arthrex, INC. | $165.96 | 2025 | |
| Si-Bone, INC. | $73.88 | 2020 | |
| Merck Sharp & Dohme LLC | $63.29 | 2019-2024 | Bridion |
| Saluda Medical Americas, INC. | $24.44 | 2024 | Evoke |
| Vertex Pharmaceuticals Incorporated | $17.53 | 2024 | |
| Medtronic USA, INC. | $11.95 | 2020 | |
| Masimo Corporation | $11.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Bellamy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.